반응형
| Global Data Intelligence Center | ||
| 구분 | 보고서 (영문) | 업로드 날짜 |
| 제약/바이오/임상시험 | PDS Biotech to Pursue Pivotal Trial in HNSCC After Exciting Phase II Results | 11-17-2023 |
| Novo Nordisk Launches Combo Trial of Pipeline Drug CagriSema versus Eli Lilly’s Newly Approved Zepbound | 11-17-2023 | |
| Post Hoc Analysis of SCORED Trial Sheds Positive Light on Inpefa for Heart Failure | 11-17-2023 | |
| Positive Phase III Data Could Help Position Ubrelvy in a Crowded Migraine Market | 11-20-2023 | |
| AstraZeneca’s Imfinzi Phase III Trial Raises Trial Design Questions | 11-21-2023 | |
| Truqap’s First Approval Is Not What AstraZeneca Was Hoping for | 11-22-2023 | |
| Roche Attempts to Expand in the Lupus Nephritis Treatment Landscape with an Oncology Drug After Promising Phase II Trials | 11-22-2023 | |
| VPAS Is Dead, Long Live VPAG—Could the UK’s New Clawback Revision Save the Day | 11-27-2023 | |
| Where do Anti-Tumor Necrosis Factor Like Cytokine Agents go After Their Initial Excitement? | 11-30-2023 | |
| BioPharmaceutical Outsourcing Report | 11-30-2023 | |
| Madrigal Ramps Up Preparations for Commercial Launch of Resmetirom in NASH | 11-30-2023 | |
| Waning Focus on Stimulant Abuse Potential Could Negatively Affect Pipeline Non-stimulants | 11-30-2023 | |
| Partnership Deals for Psychedelic Drugs Take a Trip with 500% Surge in 2023 | 12-01-2023 | |
| 질환별 | Experts Believe Gene Therapy Offers Potential to Impact Gaucher Disease Market | 11-21-2023 |
| World AIDS Day 2023 Highlights Community Leadership to End the HIV Epidemic | 12-01-2023 | |
| 컨퍼런스/심포지엄/학회 | CPHI Barcelona: A Tough Funding Environment Necessitates Integration and Flexibility for ATMP Manufacturing | 11-24-2023 |
| The Movement Towards Trial Transparency | 11-29-2023 | |
반응형
'의료기기관련기관 > 보건산업혁신창업센터' 카테고리의 다른 글
| [한국보건산업진흥원] 2022년 보건산업혁신창업센터 혁신창업멤버스 모집 (0) | 2023.04.25 |
|---|---|
| 2023년 투자유치 중개 지원 사업 전문기관 모집 (0) | 2023.03.14 |
| 2023년 특허전략 및 인허가 컨설팅 지원사업 모집공고 안내 (0) | 2023.03.14 |
